Humanigen Announces Participation and Presentation at Multiple Conferences in October
BURLINGAME, Calif.–(Business enterprise WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-phase biopharmaceutical organization concentrated on stopping and dealing with an immune[…]
Read more